Pharma News

Biocon grown by 64% in net profit at Rs 213.7 cr during fourth quarter

  • Posted on: 26 April 2019
  • By: PharmaTutor News

Biocon Ltd announced its consolidated financial results for the fourth quarter and fiscal year ended March 31st, 2019. Biocon Biologics revenue nearly doubled, led by biosimilars portfolio performance in developed and emerging markets. Branded Formulations India business reported a strong double digit growth which was offset by a decline in UAE. Generic Formulations business grew multi-fold off a low base, reflecting our focus on vertical integration in the Small Molecules business. Research Services subsidiary Syngene crossed the Rs 500 Crore Revenue milestone with a Net Profit milestone of Rs 100 Crore in Q4 on a standalone basis.

FDA permits marketing of first medical device for treatment of ADHD

  • Posted on: 22 April 2019
  • By: Shalini.Sharma

The U.S. Food and Drug Administration  permitted marketing of the first medical device to treat attention deficit hyperactivity disorder (ADHD). The prescription-only device, called the Monarch external Trigeminal Nerve Stimulation (eTNS) System, is indicated for patients ages 7 to12 years old who are not currently taking prescription ADHD medication and is the first non-drug treatment for ADHD granted marketing authorization by the FDA.

FDA approves first generic naloxone nasal spray to treat opioid overdose

  • Posted on: 22 April 2019
  • By: Shalini.Sharma

The U.S. Food and Drug Administration granted final approval of the first generic naloxone hydrochloride nasal spray, commonly known as Narcan, a life-saving medication that can stop or reverse the effects of an opioid overdose. The agency is also planning new steps to prioritize the review of additional generic drug applications for products intended to treat opioid overdose, along with the previously announced action to help facilitate an over-the-counter naloxone product.

MOU signed between Ministry of AYUSH and Council of Scientific and Industrial Research

  • Posted on: 22 April 2019
  • By: Shalini.Sharma

A Memorandum of Understanding (MOU) was signed between the Ministry of AYUSH and Council of Scientific and Industrial Research (CSIR), New Delhi today for cooperation in research and education in areas of traditional systems of medicine and its integration with modern science. The MoU was signed by Vaidya Rajesh Kotecha, Secretary, Ministry of AYUSH and Dr. Shekhar C. Mande, Director General, CSIR and Secretary, DSIR in the presence of senior officials from both the organizations.

AI can diagnose Post-traumatic Stress Disorder

  • Posted on: 22 April 2019
  • By: PharmaTutor News

A specially designed computer program can help diagnose post-traumatic stress disorder (PTSD) in veterans by analyzing their voices, a new study finds.

"Our findings suggest that speech-based characteristics can be used to diagnose this disease, and with further refinement and validation, may be employed in the clinic in the near future," says senior study author Charles R. Marmar, MD, the Lucius N. Littauer Professor and chair of the Department of Psychiatry at NYU School of Medicine.

FDA takes action to protect women’s health, orders manufacturers of surgical mesh intended for transvaginal repair of pelvic organ prolapse to stop selling all devices

  • Posted on: 19 April 2019
  • By: Shalini.Sharma

The U.S. Food and Drug Administration ordered the manufacturers of all remaining surgical mesh products indicated for the transvaginal repair of pelvic organ prolapse (POP) to stop selling and distributing their products in the U.S. immediately. The order is the latest in a series of escalating safety actions related to protecting the health of the thousands of women each year who undergo surgery transvaginally to repair POP.

Decline in measles vaccination is causing a preventable global resurgence of the disease

  • Posted on: 19 April 2019
  • By: Shalini.Sharma

In 2000, measles was declared to be eliminated in the United States, when no sustained transmission of the virus was seen in this country for more than 12 months. However, the United States and many other countries that had eliminated the disease are experiencing concerning outbreaks of measles because of declines in measles vaccine coverage. Without renewed focus on measles vaccination efforts, the disease may rebound in full force, according to a new commentary in the New England Journal of Medicine by infectious diseases experts at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and the Penn State University College of Medicine’s Milton S. Hershey Medical Center.

NIH funds study in four states to reduce opioid related deaths by 40 percent over three years

  • Posted on: 19 April 2019
  • By: Shalini.Sharma

As part of Health and Human Services Secretary Alex Azar’s cross-cutting Department initiatives to address the opioid epidemic, the National Institutes of Health today selected four research sites for the HEALing Communities Study in four states hard hit by the opioid crisis. This ambitious study aims to reduce overdose deaths by 40 percent over three years in selected communities by testing a set of proven prevention and treatment interventions, such as distribution of naloxone to reverse overdose and linking individuals in the criminal justice system with treatment for opioid addiction.

Eminence Business Media’s “2nd Annual Pharma Project & Portfolio Management Summit 2019”

  • Posted on: 17 April 2019
  • By: Shalini.Sharma

Eminence Business Media’s “2nd Annual Pharma Project & Portfolio Management Summit 2019” concluded on February 21st & 22nd, 2019 at Hotel Orchid, Mumbai. The theme of the summit was Bringing ‘Vision’ to your projects: Strategizing Innovation from Lab to Launch. The summit was an outstanding success with 90+ delegates attending the conference with Labindia Analytical Instruments Pvt. Ltd., Pharma Mantra & Global Awards and Rewards partnering the event.

Pages